🎗️Лента новостей
FDA approves Tukysa combination for HER2-positive breast cancer
The FDA has approved tucatinib plus trastuzumab and pertuzumab as front-line maintenance therapy for adults with unresectable, locally advanced or metastatic HER2-positive breast cancer following induction treatment. Tucatinib (Tukysa, Seagen), an oral tyrosine kinase inhibitor, had previously been approved in 2020 as…
В ТПУ завершили разработку модели для прогнозирования осложнений лучевой терапии при раке простаты
В ТПУ завершили разработку модели для прогнозирования осложнений лучевой терапии при раке простаты Vademec.ru
Tashy’s Story Shows Why Research Matters for Every Child Diagnosed With Cancer - Children's Cancer Institute
Tashy’s Story Shows Why Research Matters for Every Child Diagnosed With Cancer - Children's Cancer Institute Oncodaily
Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”
Anthony Letai reflects on Year One as NCI Director: “The NCI is in business” The Cancer Letter
Joanna Metzner-Sadurski: Honored to Be Part of a 25-Year Journey in Rural Cancer Research
Joanna Metzner-Sadurski: Honored to Be Part of a 25-Year Journey in Rural Cancer Research Oncodaily
Montefiore joins national study testing early-stage breast cancer treatment without surgery
Montefiore joins national study testing early-stage breast cancer treatment without surgery Bronx Times
Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival | Newswise
Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival | Newswise Newswise
10 Bladder and Urothelial Cancer Trials to Watch at ESMO 2026
10 Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 Oncodaily
Oregon Surgical Wellness adds breast surgical oncologist Sara B. Cartwright to team
Oregon Surgical Wellness adds breast surgical oncologist Sara B. Cartwright to team KMTR
Louis Vermeulen Appointed Global Head of Oncology at Roche pRED
Louis Vermeulen Appointed Global Head of Oncology at Roche pRED Oncodaily
Colorectal cancer mortality increasing in young adults in Canada
Cancer mortality for individuals aged under 50 years in Canada has significantly decreased for nine of the 10 deadliest malignancies since 2000. “This is a great news story,” Darren R. Brenner, PhD, professor at Cumming School of Medicine at University of Calgary, told Healio. However, colorectal cancer mortality has…
LSU Health New Orleans recruits internationally recognized leader to establish institution’s first academic department of radiation oncology
LSU Health New Orleans recruits internationally recognized leader to establish institution’s first academic department of radiation oncology EurekAlert! Science News Releases
Lived Experience Hub Event Opportunity: Symposium on Clinical Insights in Cancer Genome Interpretation
Lived Experience Hub Event Opportunity: Symposium on Clinical Insights in Cancer Genome Interpretation Oncodaily